The FDA has allowed a substantial amount of late reports and undated reports into its Manufacturer and User Facility Device ...

The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ issue with certain Baxter ...

One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

We are looking into a health alert, as the FDA has ruled compounded versions of popular drugs used for weight loss will no longer be available.

Activists have slammed the GRAS program, arguing it allows companies to “self-certify” the safety of food additives.

We are looking into a health alert, as the FDA has ruled compounded versions of popular drugs used for weight loss will no longer be available.

According to the agency, the 15-year-old company only presented efficacy claims for its branded medication and did not include any warnings or precautions for the tablets at a tradeshow.

The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ issue with certain Baxter Sigma Spectrum and Spectrum IQ infusion pumps. The agency’s ...